Change language dansk English suomi svenska

Generate Estimates Confirm Cancel Hide empty rows Show hidden rows DummyText

Tandlægen Kirkegade ApS Estimate generation in progress, please wait... 0%

Quicksearch from your own companies XBRLDenmark Analyst: XBRLDenmark

Loading... Loading... Loading... Loading...   Loading...

1000.0 Bankruptcy Risk  2018 2019/6 2019 2020/6 2020 2021/6 2021 2022/6 2022 2023/6 2023 2024/6 2024e N/A 2025e N/A Bankruptcy risk for industry   0.5% 0.5% 0.5% 0.5% 0.5% 0.5% 0.5% 0.5%   Bankruptcy risk   3.2% 3.0% 1.8% 3.4% 2.5% 2.6% 18.4% 18.1%   Credit score (0-100)   57 59 72 52 62 60 8 8   Credit rating   BBB BBB A BBB BBB BBB B B   Credit limit (kDKK)   0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0   How are these values calculated?   View the automatically generated explanation of bankruptcy risk 1000.0 Income statement (kDKK)  2018 2019/6 2019 2020/6 2020 2021/6 2021 2022/6 2022 2023/6 2023 2024/6 2024e N/A 2025e N/A Net sales   0 0 0 0 0 0 0 0   Gross profit   902 899 1,287 1,141 1,161 1,020 0.0 0.0   EBITDA   52.8 39.4 249 -251 -345 -639 0.0 0.0   EBIT   22.4 8.5 209 -295 -389 -683 0.0 0.0   Pre-tax profit (PTP)   21.5 6.6 208.0 -43.0 66.7 -3.7 0.0 0.0   Net earnings   5.1 3.5 177.0 -16.0 45.0 -2.9 0.0 0.0   Pre-tax profit without non-rec. items   21.5 6.6 208 -43.0 66.7 -3.7 0.0 0.0     See the entire income statement 1000.0 Balance sheet (kDKK)  2018 2019/6 2019 2020/6 2020 2021/6 2021 2022/6 2022 2023/6 2023 2024/6 2024e N/A 2025e N/A Tangible assets total   257 246 324 280 236 192 0.0 0.0   Shareholders equity total   37.0 40.5 221 205 250 247 197 197   Interest-bearing liabilities   182 166 194 317 221 187 0.0 0.0   Balance sheet total (assets)   360 356 683 735 733 690 197 197   Net Debt   154 162 194 317 221 187 -197 -197     See the entire balance sheet 1000.0 Volume  2018 2019/6 2019 2020/6 2020 2021/6 2021 2022/6 2022 2023/6 2023 2024/6 2024e N/A 2025e N/A Net sales   0 0 0 0 0 0 0 0   Net sales growth   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Gross profit   902 899 1,287 1,141 1,161 1,020 0.0 0.0   Gross profit growth   0.0% -0.3% 43.2% -11.3% 1.8% -12.1% -100.0% 0.0%   Employees   0 0 3 3 4 4 0 0   Employee growth %   0.0% 0.0% 0.0% 0.0% 33.3% 0.0% -100.0% 0.0%   Employee expenses   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   Balance sheet total (assets)   360 356 683 735 733 690 197 197   Balance sheet change%   0.0% -1.1% 91.8% 7.6% -0.3% -5.9% -71.5% 0.0%   Added value   52.8 39.4 249.1 -250.6 -345.0 -638.8 0.0 0.0   Added value %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Investments   227 -42 38 -88 -88 -88 -192 0   Net sales trend   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   EBIT trend   1.0 2.0 3.0 -1.0 -2.0 -3.0 0.0 0.0   1000.0 Profitability  2018 2019/6 2019 2020/6 2020 2021/6 2021 2022/6 2022 2023/6 2023 2024/6 2024e N/A 2025e N/A EBITDA %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   EBIT %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   EBIT to gross profit (%)   2.5% 0.9% 16.3% -25.8% -33.5% -66.9% 0.0% 0.0%   Net Earnings %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Profit before depreciation and extraordinary items %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Pre tax profit less extraordinaries %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   ROA %   6.2% 2.4% 40.3% -5.2% 10.7% -0.1% 0.0% 0.0%   ROI %   10.2% 4.0% 60.7% -6.9% 13.9% -0.2% 0.0% 0.0%   ROE %   13.7% 9.1% 135.6% -7.5% 19.8% -1.2% 0.0% 0.0%   1000.0 Solidity  2018 2019/6 2019 2020/6 2020 2021/6 2021 2022/6 2022 2023/6 2023 2024/6 2024e N/A 2025e N/A Equity ratio %   10.9% 11.4% 32.3% 27.8% 34.1% 35.8% 100.0% 100.0%   Relative indebtedness %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Relative net indebtedness %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Net int. bear. debt to EBITDA, %   291.2% 411.8% 77.8% -126.6% -64.0% -29.3% 0.0% 0.0%   Gearing %   491.0% 409.5% 87.9% 155.0% 88.5% 75.8% 0.0% 0.0%   Net interest   0 0 0 0 0 0 0 0   Financing costs %   0.9% 1.1% 0.9% 2.4% 4.4% 1.3% 0.0% 0.0%   1000.0 Liquidity  2018 2019/6 2019 2020/6 2020 2021/6 2021 2022/6 2022 2023/6 2023 2024/6 2024e N/A 2025e N/A Quick Ratio   0.3 0.3 0.7 0.6 0.3 0.3 0.0 0.0   Current Ratio   0.3 0.3 0.7 0.6 0.3 0.3 0.0 0.0   Cash and cash equivalent   28.1 3.6 0.0 0.0 0.0 0.0 0.0 0.0   1000.0 Capital use efficiency  2018 2019/6 2019 2020/6 2020 2021/6 2021 2022/6 2022 2023/6 2023 2024/6 2024e N/A 2025e N/A Trade debtors turnover (days)   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   Trade creditors turnover (days)   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   Current assets / Net sales %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Net working capital   -228.0 -213.4 -131.9 -172.2 -276.4 -251.5 0.0 0.0   Net working capital %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   1000.0 Employee efficiency  2018 2019/6 2019 2020/6 2020 2021/6 2021 2022/6 2022 2023/6 2023 2024/6 2024e N/A 2025e N/A Net sales / employee   0 0 0 0 0 0 0 0   Added value / employee   0 0 83 -84 -86 -160 0 0   Employee expenses / employee   0 0 0 0 0 0 0 0   EBITDA / employee   0 0 83 -84 -86 -160 0 0   EBIT / employee   0 0 70 -98 -97 -171 0 0   Net earnings / employee   0 0 59 -5 11 -1 0 0